Thermo Fisher Scientific recently announced that the Ministry of Health, Labour and Welfare (MHLW), Japan's regulatory a...
CAC Corporation has signed a partnership agreement with rfxcel Corporation in the pharmaceutical traceability field...
AbbVie and Eisai have announced that they have received approval for an additional indication of HUMIRA®, a fully hu...
The Japanese pharma market is expected to grow quickly in 2019 following the release of a new report published ahead of ...
Sosei Group Corporation, has announced that the first healthy subject has been dosed with a novel small molecule HTL0030...
Generex Biotechnology has announced that the company’s subsidiary Regentys Corporation, a clinical stage regenerat...
KCI, an Acelity Company, recently announced the launch of ABTHERA™ Open Abdomen Negative Pressure Therapy in Japan...
Fujitsu has announced the development of Fujitsu Healthcare Solution Healthcare Personal service Platform, a platform-as...
Eisai Co., Ltd. has announced that it has submitted an application to the European Medicines Agency (EMA) for its in-hou...
Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide b...
Seattle Genetics, Inc. has announced that its collaborator, Takeda Pharmaceutical Company Limited, received approval fro...
AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, has announced that the Com...
Hitachi, Ltd., Jichi Medical University (JMU), International University of Health and Welfare (IUHW) and Chuo University...
Codexis, Inc. has recently announced a multi-year, exclusive supply agreement with KYORIN Pharmaceutical Co., Ltd. for t...
Kyowa Hakko Kirin Co., Ltd. announced the initiation of a phase 2 clinical study in Japan for tenapanor, a small mol...
Eiger BioPharmaceuticals, Inc., focused on the development and commercialization of targeted therapies for rare and ultr...
Chugai Pharmaceutical has announced that Roche has joined the World Federation of Hemophilia (WFH) Humanitarian Aid...
Taiho Pharmaceutical and Cullinan Oncology, LLC announced an agreement to develop TAS6417, a novel EGFR (epidermal growt...
